Becton Dickinson to merge diagnostic units
This article was originally published in Clinica
Executive Summary
Becton Dickinson is to consolidate three of its subsidiary companies to form a single bioscience/diagnostics business. The move should be completed by January 1999. Clateo Castellini, Becton's CEO, chairman and president, said: "The in vitro diagnostic industry is rapidly changing, the clinical laboratory market is consolidating, and our customers are creating larger, more automated laboratories. We believe this new structure gives us the scope and reach to capitalise on new opportunities."